A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

L Sforzini, C Worrell, M Kose, IM Anderson… - Molecular …, 2022 - nature.com
Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD)
as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the …

Management of treatment-resistant depression: challenges and strategies

D Voineskos, ZJ Daskalakis… - … disease and treatment, 2020 - Taylor & Francis
Abstract Treatment-resistant depression (TRD) is a subset of Major Depressive Disorder
which does not respond to traditional and first-line therapeutic options. There are several …

Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial

EJ Cole, AL Phillips, BS Bentzley… - American Journal of …, 2022 - psychiatryonline.org
Objective: Depression is the leading cause of disability worldwide, and half of patients with
depression have treatment-resistant depression. Intermittent theta-burst stimulation (iTBS) is …

Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial

AK Davis, FS Barrett, DG May, MP Cosimano… - JAMA …, 2021 - jamanetwork.com
Importance Major depressive disorder (MDD) is a substantial public health burden, but
current treatments have limited effectiveness and adherence. Recent evidence suggests that …

Defining treatment‐resistant depression

BN Gaynes, L Lux, G Gartlehner, G Asher… - Depression and …, 2020 - Wiley Online Library
Background Varying conceptualizations of treatment‐resistant depression (TRD) have made
translating research findings or systematic reviews into clinical practice guidelines …

The clinical characterization of the adult patient with depression aimed at personalization of management

M Maj, DJ Stein, G Parker, M Zimmerman… - World …, 2020 - Wiley Online Library
Depression is widely acknowledged to be a heterogeneous entity, and the need to further
characterize the individual patient who has received this diagnosis in order to personalize …

Biomarkers for depression: recent insights, current challenges and future prospects

R Strawbridge, AH Young, AJ Cleare - … disease and treatment, 2017 - Taylor & Francis
A plethora of research has implicated hundreds of putative biomarkers for depression, but
has not yet fully elucidated their roles in depressive illness or established what is abnormal …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute …

M Bauer, A Pfennig, E Severus… - The world journal of …, 2013 - Taylor & Francis
Objectives. This 2013 update of the practice guidelines for the biological treatment of
unipolar depressive disorders was developed by an international Task Force of the World …

[HTML][HTML] Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant …

S Bulteau, A Laurin, M Pere, G Fayet… - Brain Stimulation, 2022 - Elsevier
Background Recently intermittent theta burst stimulation (iTBS) proved to be non-inferior to
conventional repetitive transcranial magnetic stimulation (10 Hz rTMS) in unipolar …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines

A Cleare, CM Pariante, AH Young… - Journal of …, 2015 - journals.sagepub.com
A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …